JNJ-26076713

Overview

JNJ-26076713 is a potent and orally active alpha V integrin antagonist with IC 50 values of 2.3 nM and 6.3 nM for alpha(V)beta(3) and alpha(V)beta(5), respectively. JNJ-26076713 inhibits retinal neovascularization.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Integrin

Product Information

• Catalog No.: HY-116030
• CAS No.: 669076-03-3
• Molecular Formula: C29H38N4O3
• Molecular Weight: 490.64
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source